Amit Khurana from Dolat Capital discusses market challenges due to the impending Trump administration and global events. He recommends a focused, bottom-up approach, emphasizing the potential in pharma, neutral stance on IT with a focus on digital and product sides, and cautious outlook on FMCG due to urban slowdown. Positive on selected rural consumption stocks.
